Odyssey Health (ODYY) Net Income Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Net Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 41.89% |
| Jan 31, 2026 | 7.32% |
| Oct 31, 2025 | 10.95% |
| Jul 31, 2025 | 33.15% |
| Apr 30, 2025 | 56.48% |
| Jan 31, 2025 | 55.34% |
| Oct 31, 2024 | 28.01% |
| Jul 31, 2024 | 14.94% |
| Apr 30, 2024 | -49.87% |
| Jan 31, 2024 | -64.92% |
| Oct 31, 2023 | -50.58% |
| Jul 31, 2023 | -52.45% |
| Apr 30, 2023 | -77.17% |
| Jan 31, 2023 | -46.71% |
| Oct 31, 2022 | -102.31% |
| Jul 31, 2022 | -78.57% |
| Apr 30, 2022 | -107.79% |
| Jan 31, 2022 | -133.95% |
| Oct 31, 2021 | -137.32% |
| Jul 31, 2021 | -133.89% |